Inventor · disambiguated record
Daniel Mercola
Also filed as: MERCOLA DANIEL · MERCOLA DANIEL A
4 granted patents·6 pending applications·75 citations·filing 1999–2013
79Inventor score
Files withMERCOLA DANIEL3MCCLELLAND MICHAEL1UNIV CALIFORNIA1UNIV CALIFORNIA IRVINE1WACHSMAN WILLIAM1
Top patents by PatentIndex Score
10 records- 0184US6982145B1Isolation and identification of control sequences and genes modulated by transcription factorsMERCOLA DANIEL·Filed 2001·Granted Jan 3, 2006·32 cites·10 claims
- 0281US6579856B2Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapiesFiled 2001·Granted Jun 17, 2003·21 cites·8 claims
- 0371US8781750B2Cell-type-specific patterns of gene expressionWACHSMAN WILLIAM·Filed 2005·Granted Jul 15, 2014·8 cites·4 claims
- 0458US2011236903A1Materials and methods for determining diagnosis and prognosis of prostate cancerMCCLELLAND MICHAEL·Filed 2009·Application pending·0 cites
- 0555US6410233B2Isolation and identification of control sequences and genes modulated by transcription factorsFiled 1999·Granted Jun 25, 2002·14 cites·9 claims
- 0655US2014011861A1Materials and Methods for Determining Diagnosis and Prognosis of Prostate CancerUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 0746US2015218655A1Biomarkers for prostate cancer prognosisUNIV CALIFORNIA IRVINE·Filed 2013·Application pending·0 cites
- 0841US2016138108A1Stroma biomarkers for the diagnosis of prostate cancerMERCOLA DANIEL·Filed 2013·Application pending·0 cites
- 0937US2005261226A1Methods and compositions for the treatment of cancer with oligonucleotides directed against Egr-1MERCOLA DANIEL·Filed 2005·Application pending·0 cites
- 1029US2003060433A1Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapiesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Mercola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →